AnteoTech Ltd (AU:ADO)
ASX:ADO
ADO Stock Chart & Stats
AU$0.02
>-AU$0.01(-5.00%)
At close: 4:00 PM EST
AU$0.02
>-AU$0.01(-5.00%)
Day’s Range― - ―
52-Week Range<AU$0.01 - AU$0.03
Previous CloseN/A
Volume1.67M
Average Volume (3M)1.47M
Market Cap
AU$35.68M
Enterprise ValueAU$37.09M
Total Cash (Recent Filing)AU$1.44M
Total Debt (Recent Filing)AU$2.85M
Price to Earnings (P/E)―
Beta1.20
Next Earnings
Sep 01, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)0.00
Shares Outstanding2,973,138,700
10 Day Avg. Volume1,501,441
30 Day Avg. Volume1,471,917
Financial Highlights & Ratios
PEG Ratio0.14
Price to Book (P/B)10.79
Price to Sales (P/S)35.07
P/FCF Ratio-5.62
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Proprietary TechnologyOwning proprietary coating and binding technologies creates a durable technical moat across diagnostics and battery applications. This supports product differentiation, negotiating leverage in commercial agreements, and multiple commercialization routes (product sales, partnerships, licensing) over the next months.
Manageable LeverageA moderate debt-to-equity ratio (~0.62) indicates the company is not over-levered, which preserves financial flexibility. That balance sheet headroom helps fund ongoing R&D and commercialisation efforts without excessive bankruptcy risk or immediate refinancing pressure in the medium term.
High Gross Profit PotentialA high gross profit margin implies the core products and materials have attractive unit economics. If operating efficiencies and scale improve, gross margin strength can translate into better operating leverage and eventual path to positive operating profit, supporting durable margin recovery.
Bears Say
Severe Revenue VolatilityExtreme revenue swings reflect inconsistent demand, lumpy contract timing, or failed commercial scale-up. Such volatility undermines forecasting, hinders multi-period planning for manufacturing and sales, and raises the risk that near-term commercialisation efforts will not deliver stable recurring revenues.
Negative Operating & Free Cash FlowPersistent negative operating and free cash flows erode liquidity and force reliance on external financing. Over a 2–6 month horizon this constrains the company's ability to invest in scale-up, qualify products with partners, or absorb commercialization delays without dilutive capital raises or covenant pressures.
Persistent Losses And Negative ROEConsistent negative profitability and a negative ROE indicate the company is not generating returns on shareholder capital. That limits internal funding for growth, increases dependence on external capital, and makes sustained investment in R&D or manufacturing commercially risky until margins improve.
AnteoTech Ltd News
ADO FAQ
What was AnteoTech Ltd’s price range in the past 12 months?
AnteoTech Ltd lowest share price was <AU$0.01 and its highest was AU$0.03 in the past 12 months.
What is AnteoTech Ltd’s market cap?
AnteoTech Ltd’s market cap is AU$35.68M.
When is AnteoTech Ltd’s upcoming earnings report date?
AnteoTech Ltd’s upcoming earnings report date is Sep 01, 2026 which is in 157 days.
How were AnteoTech Ltd’s earnings last quarter?
AnteoTech Ltd released its earnings results on Feb 24, 2026. The company reported AU$0 earnings per share for the quarter, the consensus estimate of N/A by AU$0.
Is AnteoTech Ltd overvalued?
According to Wall Street analysts AnteoTech Ltd’s price is currently Overvalued.
Does AnteoTech Ltd pay dividends?
AnteoTech Ltd does not currently pay dividends.
What is AnteoTech Ltd’s EPS estimate?
AnteoTech Ltd’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does AnteoTech Ltd have?
AnteoTech Ltd has 2,973,138,700 shares outstanding.
What happened to AnteoTech Ltd’s price movement after its last earnings report?
AnteoTech Ltd reported an EPS of AU$0 in its last earnings report, expectations of N/A. Following the earnings report the stock price went down -7.692%.
Which hedge fund is a major shareholder of AnteoTech Ltd?
Currently, no hedge funds are holding shares in AU:ADO
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
AnteoTech Ltd Stock Smart Score
Underperform
1
2
3
4
5
6
7
8
9
10
Blogger Sentiment
Bullish
AU:ADO Sentiment 98%
Sector Average 69%
Sector Average 69%
News Sentiment
Very Bearish
Bullish news 0%
Bearish news 100%
Bearish news 100%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-10.00%
12-Months-Change
Fundamentals
Return on Equity
-142.30%
Trailing 12-Months
Asset Growth
-58.00%
Trailing 12-Months
Company Description
AnteoTech Ltd
AnteoTech Limited, a surface chemistry company, develops, commercializes, manufactures, and distributes products for the life sciences, diagnostics, energy, and medical device markets primarily in Australia. Its products include AnteoBind ready-to-use kits to streamline and enhance the conjugation process; AnteoX, an additive that reinforces battery binders helping maximize performance of silicon containing anodes; EuGeni, a COVID-19 antigen rapid test; and AnteoRelease and AnteoCoat. The company was formerly known as Anteo Diagnostics Limited and changed its name to AnteoTech Limited in November 2019. AnteoTech Limited is headquartered in Eight Mile Plains, Australia.
Technical Analysis
Cynata Therapeutics Limited
―
Prescient Therapeutics Limited
―
Starpharma Holdings Limited
―
Avecho Biotechnology Limited
―
Proteomics International Laboratories Ltd.
―